About this market
Growing focus on stabilization systems to drive growth in the market. Cranial stabilization systems provide adequate support of the head and improved positioning of the patient, which are likely to contribute to the growth of the cranial fixation and stabilization systems. The analysts have predicted that the cranial fixation and stabilization systems market will register a CAGR of more than 5% by 2023.
Market Overview
Increasing prevalence of neurological disorders
Cranial fixation and stabilization systems are used to treat skull fractures, traumatic brain surgeries, and other neurological disorders. These systems will hold the skull and helps in maintaining it in position which is convenient for surgeons.
Stringent regulations and product recall
Cranial stabilization systems are classified under Class II and Class III medical devices and are subjected to stringent regulatory standards. Gaining regulatory approval of Class II and Class III devices is often difficult, unpredictable, and subjective. This poses as a challenge to the market.
For the detailed list of factors that will drive and challenge the growth of the cranial fixation and stabilization systems market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Stryker and Zimmer Biomet the competitive environment is quite intense. Factors such as the rising focus on stabilization systems and the increasing prevalence of neurological disorders, will provide considerable growth opportunities to cranial fixation and stabilization systems manufactures. B. Braun Melsungen, Integra LifeSciences, Johnson & Johnson, Medtronic, Stryker, and Zimmer Biomet are some of the major companies covered in this report.